systems. To better understand patients’ available options for managing their cancer-related pain, we conducted this literature review. Methods: NIH database, Cochrane library, and Embase were thoroughly searched, and inclusion or exclusion criteria were
Search Results
BPI23-016: Interventional Pain Management in Outpatient Setting for Cancer Patients: A Review of Literature
FNU Anamika, Akshit Chitkara, Anh-Tram Bui, Quang Nguyen, Arshia Adib, Pramil Cheriyath, and Karamjeet Sandhu
CLO24-067: Evaluating Kaposi Sarcoma in Kidney Transplant Patients: A Systematic Review and Meta-Analysis.
Sakditad Saowapa, Natchaya Polpichai, Pharit Siladech, Chalothorn Wannaphut, Manasawee Tanariyakul, Phuuwadith Wattanachayakul, and Pakin Lalitnithi
review was to identify the prevalence and treatment of KS in renal transplant patients. Design and Methodology PubMed, Cochrane Library, and Google Scholar databases were searched for studies until October 2023. Full-text studies with similar research
CRE24-040: Gluteal Metastasis of Intrahepatic Cholangiocarcinoma: Clinical Case and Literature Review
Natalia de la Puente Mota, Yolanda Gómez Fandiño, Francisco Javier Anguita Ramos, María López López, Mariaclaudia Ocharán Puell, Beatriz Carnero López, Jorge González Ramírez, Adriana Fernández García, and José Conde Vales
Objective: To present a case of intrahepatic cholangiocarcinoma with metastasis to the left gluteus maximus muscle and provide a current literature review. Case Presentation: A 74-year-old male with complex cardiac and oncological history was
Multiple Successful Desensitizations to Brentuximab Vedotin: A Case Report and Literature Review
Michael D. DeVita, Andrew M. Evens, Steven T. Rosen, Paul A. Greenberger, and Adam M. Petrich
journal CE activity: 1) review the learning objectives and author disclosures; 2) study the education content; 3) take the posttest with a 66% minimum passing score and complete the evaluation at http://education.nccn.org/node/43682 ; and 4) view
An Unusual Presentation of Chronic Myelogenous Leukemia: A Review of Isolated Central Nervous System Relapse
Scott M. Lindhorst, Richard D. Lopez, and Ronald D. Sanders
journal CE activity: 1) review the learning objectives and author disclosures; 2) study the education content; 3) take the post-test with a 70% minimum passing score and complete the evaluation at http://education.nccn.org/node/24439 ; and 4) view
A Review of the Symptomatic Management of Malignant Gliomas in Adults
Umang Shah and Tara Morrison
with glioblastoma . Neurology 2009 ; 73 : 1207 – 1213 . 10 Usery JB Michael LM II Sills AK Finch CK . A prospective evaluation and literature review of levetiracetam use in patients with brain tumors and seizures . J Neurooncol 2010
Digital Rectal Examination Remains a Key Prognostic Tool for Prostate Cancer: A National Cancer Database Review
Jenna F. Borkenhagen, Daniel Eastwood, Deepak Kilari, William A. See, Jonathan D. Van Wickle, Colleen A. Lawton, and William A. Hall
investigators affiliated with accredited cancer programs. 15 Exempt status was obtained from the Medical College of Wisconsin Institutional Review Board for the current study because it did not meet criteria for human subject research. There were 1
Review of Late Complications of Treatment and Late Relapse in Testicular Cancer
Eleni Efstathiou and Christopher J. Logothetis
worldwide: a review . J Urol 2003 ; 170 : 5 – 11 . 2. Shahidi M Norman AR Dearnaley DP . Late recurrence in 1263 men with testicular germ cell tumors. Multivariate analysis of risk factors and implications for management . Cancer 2002 ; 95
Short Screening Tools for Cancer-Related Distress: A Review and Diagnostic Validity Meta-Analysis
Alex J. Mitchell
), but some use a visual analog format. This review and brief meta-analysis examines the merits of short tools with 5 to 14 items taking 2 to 5 minutes to complete, and ultra-short screening tools of 1 to 4 items taking less than 2 minutes to complete. 14
CLO19-059: A Systematic Review and Meta- Analysis of Randomized Controlled Trials to Evaluate the Risk of Health-Related Quality of Life Events in Patients With Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer Treated With CDK 4/6 Inhibitors
Rachana Yendala, Kyaw Thein, Sriman Swarup, Anita Sultan, Somedeb Ball, Miguel Quirch, Myo H. Zaw, Yin M. Myat, and Catherine Jones
/6 activity is over expressed, which can lead to amplification or overexpression of the genes encoding for CDK 4/6 or the cyclin D, ultimately leading to endocrine therapy resistance. We undertook a systematic review and meta-analysis of randomized controlled
